Bodycote (LON:BOY - Get Free Report) had its price target increased by equities researchers at Royal Bank Of Canada from GBX 650 ($8.63) to GBX 775 ($10.29) in a note issued to investors on Thursday, Marketbeat.com reports. The firm presently has an "outperform" rating on the stock. Royal Bank Of Canada's target price points to a potential upside of 22.63% from the stock's current price.
Bodycote Stock Performance
LON BOY traded up GBX 5 ($0.07) on Thursday, hitting GBX 632 ($8.39). 189,340 shares of the stock were exchanged, compared to its average volume of 503,842. The company has a debt-to-equity ratio of 20.84, a current ratio of 0.81 and a quick ratio of 0.74. The business's fifty day moving average is GBX 582.07 and its 200 day moving average is GBX 577.01. Bodycote has a 52 week low of GBX 449.40 ($5.97) and a 52 week high of GBX 701 ($9.31). The company has a market capitalization of £1.13 billion, a PE ratio of 19.02, a P/E/G ratio of 1.44 and a beta of 1.18.
Bodycote (LON:BOY - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The company reported GBX 21.30 ($0.28) earnings per share for the quarter. Bodycote had a net margin of 8.01% and a return on equity of 8.14%. Research analysts anticipate that Bodycote will post 54.0540541 EPS for the current fiscal year.
Bodycote Company Profile
(
Get Free Report)
The leading provider of heat treatment and specialist thermal processing services worldwide.
Heat treatment encompasses a variety of techniques and specialist engineering processes which improve the properties of metals and alloys and extend the life of components and is a vital part of any manufacturing process.
Bodycote is uniquely placed via our global network and the experience and knowledge of our people to offer high quality, reliable and cost-effective services to manufacturers whatever their size or market sector.
Read More
Before you consider Bodycote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bodycote wasn't on the list.
While Bodycote currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.